Of private equity, research, and drug development
The acquisition of First Data, a credit-card processing company, by the private equity firm Kohlberg Kravis Roberts & Co. means there will be $29 billion less for the capital markets, according to MedTech Futures columnist Ogan Gurel. But under the current paradigm, investors are shying...